Stroke Trial, Recruiting NCT03485040 Sponsor: Massachusetts General Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT03485040
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 90 years old
  • People who have weakness in an arm or hand following an ischemic (blockage) or hemorrhagic (bleeding) stroke, measured by a standard stroke assessment tool
  • People who are able to follow simple instructions given in English
  • People who are alert and aware enough to respond to basic questions, as measured by a standard stroke assessment tool (confirm with trial site)
  • People whose overall medical condition has been assessed as stable by their primary medical team
  • People who are currently admitted as inpatients on the stroke neurology service at MGH (Massachusetts General Hospital)

Who may not be able to join:

  • People with a previous history of a developmental condition, neurological condition, or major mental health disorder that has caused difficulty with day-to-day functioning
  • People with a previous history of vision or hearing problems that would make it difficult to take part in testing
  • People who have an uncontrolled seizure disorder
  • People for whom EEG equipment (sensors placed on the scalp to measure brain activity) cannot safely be used

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David J Lin, MD, Neurologist

Phone: 617-726-1311

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 June 2017
Est. completion
30 June 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Fugl-Meyer Arm Motor Assessment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov